⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SBFM News
Sunshine Biopharma Inc.
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
accessnewswire.com
SBFM
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
accessnewswire.com
SBFM
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
accessnewswire.com
SBFM
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
accessnewswire.com
SBFM